Digging into the 6-month first-in-human clinical trial data from SpyGlass Pharma
February 14th 2023Patrick Mooney, CEO of SpyGlass Pharma, sits down to discuss the 6-month first-in-human clinical trial data of their drug delivery platform with bimatoprost, which is implanted during routine cataract surgery.